Works matching Heparin (drug interactions)

Results: 17

Promising Drug Fondaparinux for the Treatment of COVID-19: an In Silico Analysis of Low Molecular Weight Heparin, Direct Oral Anticoagulant, and Antiplatelet Drug Interactions with Host Protease Furin.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 425, doi. 10.1007/s10557-022-07406-z

By:

Ertan-Bolelli, Tugba;
Bolelli, Kayhan;
Elçi, Sıtkı Doga;
Belen-Apak, F. Burcu

Publication type:

Article

Pharmacologic Implications of Heparin Interactions with Other Drugs.

Published in:

Drug Metabolism Reviews, 1976, v. 5, n. 2, p. 281, doi. 10.3109/03602537609029980

By:

Colburn, Wayne A.

Publication type:

Article

Clinically significant drug interactions with agents specific for migraine attacks.

Published in:

2001

By:

Eadie, M.J.

Publication type:

journal article

Clinical pharmacokinetics of tirofiban, a nonpeptide glycoprotein IIb/IIIa receptor antagonist: comparison with the monoclonal antibody abciximab.

Published in:

2002

By:

Kondo, K.;
Umemura, K.;
Kondo, Kazunao;
Umemura, Kazuo

Publication type:

journal article

Thrombolytics: drug interactions of clinical significance.

Published in:

2000

By:

Harder, S.;
Klinkhardt, U.

Publication type:

journal article

ENHANCING DRUG-TARGET INTERACTIONS THROUGH DUAL-DRUG DOCKING: A COMPUTATIONAL STUDY OF DICLOFENAC-HEPARIN COMPLEXES WITH FACTOR X<sub>A</sub>.

Published in:

Journal of Science & Arts, 2024, v. 24, n. 4, p. 973, doi. 10.46939/J.Sci.Arts-24.4-b04

By:

AMZOIU, MANUEL-OVIDIU;
TAISESCU, OANA;
AMZOIU, EMILIA;
CHELU, VASILE ALEXANDRU;
POPESCU, SOFIA;
RAU, GABRIELA;
CIOCILTEU, MARIA VIORICA;
MANDA, COSTEL-VALENTIN

Publication type:

Article

Potential In Vitro Interaction Between Tenecteplase and Unfractionated Heparin.

Published in:

Pharmacotherapy, 2004, v. 24, n. 9, p. 1154, doi. 10.1592/phco.24.13.1154.38097

By:

Tsikouris, James P.;
Martin, Christopher P.;
Cox, Craig D.;
Ziska, Martin;
Suarez, Jose A.;
Meyerrose, Gary E.

Publication type:

Article

Pharmacokinetic and pharmacodynamic interactions between palifermin and heparin.

Published in:

Journal of Clinical Pharmacology, 2015, v. 55, n. 10, p. 1109, doi. 10.1002/jcph.516

By:

Yang, Bing‐Bing;
Gillespie, Brad;
Smith, Brian;
Smith, William;
Lissmats, Agneta;
Rudebeck, Mattias;
Kullenberg, Torbjörn;
Olsson, Birgitta

Publication type:

Article

Bubrežna funkcija i antikoagulansi.

Published in:

Medicus (1330-013X), 2024, v. 33, n. 1, p. 107

By:

PRKAČIN, INGRID

Publication type:

Article

Intramural Bowel Hematoma Presenting as Small Bowel Obstruction in a Patient on Low-Molecular-Weight Heparin.

Published in:

2018

By:

Choi, Beatrix Hyemin;
Koeckert, Michael;
Tomita, Sandra

Publication type:

Case Study

Clinical Weighting of Drug-Drug Interactions in Hospitalized Elderly.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2016, v. 118, n. 4, p. 298, doi. 10.1111/bcpt.12495

By:

Juárez‐Cedillo, Teresa;
Martinez‐Hernández, Cynthia;
Hernández‐Constantino, Angel;
Garcia‐Cruz, Juan Carlos;
Avalos‐Mejia, Annia M;
Sánchez‐Hurtado, Luis A.;
Islas Perez, Valentin;
Hansten, Philip D.

Publication type:

Article

EVALUATION OF DRUG RELATED PROBLEMS (DRPs) TREATMENT OF CHOLELITHIASIS WITH DYSPEPSIA DISEASE AT THE INTERNAL DISEASE WARD OF PGI CIKINI HOSPITAL.

Published in:

Wood Industry / Drvna Industrija, 2015, v. 6, n. 1, p. 1751

By:

Karyanti, Sri Dwi Mei;
Rahmatillah, Diana Laila;
Efi, Aprilita Rinayanti

Publication type:

Article

EVALUATION OF DRUG RELATED PROBLEM IN TREATMENT OF APPENDICITIS PATIENT.

Published in:

Wood Industry / Drvna Industrija, 2015, v. 6, n. 1, p. 1707

By:

Mislu, Siska;
Rahmatillah, Diana Laila;
Rinayanti, Aprilita

Publication type:

Article

Pharmacodynamic and pharmacokinetic drug interactions reported to VigiBase, the WHO global individual case safety report database.

Published in:

European Journal of Clinical Pharmacology, 2011, v. 67, n. 6, p. 633, doi. 10.1007/s00228-010-0979-y

By:

Strandell, Johanna;
Wahlin, Stina

Publication type:

Article

Comparison of mechanisms after post-hoc analyses of the drotrecogin alfa (activated) and antithrombin III trials in severe sepsis.

Published in:

Annals of Medicine, 2004, v. 36, n. 3, p. 194, doi. 10.1080/07853890410027943

By:

Wiedermann, Christian J.;
Kaneider, Nicole C.

Publication type:

Article

Potential drug-drug interactions in inpatients treated at the Internal Medicine ward of Tikur Anbessa Specialized Hospital.

Published in:

Drug, Healthcare & Patient Safety, 2017, v. 9, p. 71, doi. 10.2147/DHPS.S126336

By:

Tesfaye, Zelalem Tilahun;
Nedi, Teshome

Publication type:

Article

Considerations and challenges with existing treatments for thrombosis in cancer patients.

Published in:

American Journal of Health-System Pharmacy, 2005, v. 62, p. S7, doi. 10.1093/ajhp/62.22_Supplement_5.S7

By:

Schwartz, Rowena N.

Publication type:

Article